2023-10-18 22:15:10
Seoul, South Korea (ots/PRNewswire) – Yuyu Pharma will be attending CPHI Worldwide in Barcelona, Spain from October 24th to 26th.
Yuyu Business Development Team will meet great partners at Booth No. 7G30 in the Korea Trade Association Pavilion to introduce Yuyu’s export products such as new modified drug Maxmarvil EC tablet, Yuhylyx soft capsules, Yuvaro and Senuvela tablets
In particular, Yuyu will focus on promoting projects currently in development, such as a reduced size dutasteride and a dutasteride-tamsulosin combination drug. These projects are being developed with the aim of gaining a foothold in the American and European markets for benign prostatic hyperplasia.
Danny Kang, Yuyu’s export manager, said: “As always, we look forward to active discussions with our partners at our CPHI stand. I hope to also meet new potential partners.”
Information regarding Yuyu Pharma
With over 80 years of experience in the healthcare industry, Yuyu Pharma (KRX: 000220) is a fast-growing global pharmaceutical company founded in Seoul, South Korea. Yuyu is committed to developing innovative therapeutics in the fields of neurology, dermatology, urology and ophthalmology. Yuyu is committed to improving the quality of life and well-being of all people through the development of innovative healthcare products and services.
Questions & Contact:
Hojin Yoon,
hjyoon@yuyu.co.kr
1697668171
#Yuyu #Pharma #participates #CPHI #Worldwide
